Evidence map›Paper›PMID 24481062›Full record

ArticleInternational journal of molecular sciences2014

Risk-association of five SNPs in TOX3/LOC643714 with breast cancer in southern China.

Xuanqiu He, Guangyu Yao, Fenxia Li, Ming Li, Xuexi Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Risk Association ofCurrent oncology (Toronto, Ont.) · 2022
    Article
  4. Article
  5. Article
  6. AnJournal of genetics · 2019
    Article
  7. Association ofEXCLI journal · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TOX gene: a novel target for human cancer gene therapy.American journal of cancer research · 2015
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xuanqiu HeThe First Clinical College, Southern Medical University, Guangzhou 510515, China. lmsh815@163.com.
Guangyu YaoBreast Center Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. ygy531@163.com.
Fenxia LiSchool of Biotechnology, Southern Medical University, Guangzhou 510515, China. lifenxia123@gmail.com.
Ming LiSchool of Biotechnology, Southern Medical University, Guangzhou 510515, China. mingli2006_2006@126.com.
Xuexi YangSchool of Biotechnology, Southern Medical University, Guangzhou 510515, China. yxxzb@sohu.com.
Southern Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The specific mechanism by which low-risk genetic variants confer breast cancer risk is currently unclear, with contradictory evidence on the role of single nucleotide polymorphisms (SNPs) in TOX3/LOC643714 as a breast cancer susceptibility locus. Investigations of this locus using a Chinese population may indicate whether the findings initially identified in a European population are generalizable to other populations, and may provide new insight into the role of genetic variants in the etiology of breast cancer. In this case-control study, 623 Chinese female breast cancer patients and 620 cancer-free controls were recruited to investigate the role of five SNPs in TOX3/LOC643714 (rs8051542, rs12443621, rs3803662, rs4784227, and rs3112612); Linkage disequilibrium (LD) pattern analysis was performed. Additionally, we evaluated how these common SNPs influence the risk of specific types of breast cancer, as defined by estrogen receptor (ER) status, progesterone receptor (PR) status and human epidermal growth factor receptor 2 (HER2) status. Significant associations with breast cancer risk were observed for rs4784227 and rs8051542 with odds ratios (OR) of 1.31 ((95% confidence intervals (CI), 1.10-1.57)) and 1.26 (95% CI, 1.02-1.56), respectively, per T allele. The T-rs8051542 allele was significantly associated with ER-positive and HER2-negative carriers. No significant association existed between rs12443621, rs3803662, and rs3112612 polymorphisms and risk of breast cancer. Our results support the hypothesis that the applicability of a common susceptibility locus must be confirmed among genetically different populations, which may together explain an appreciable fraction of the genetic etiology of breast cancer.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAgedAged, 80 and overAllelesApoptosis Regulatory ProteinsBreast NeoplasmsChinaErb-b2 Receptor Tyrosine KinasesFemaleHigh Mobility Group ProteinsHumansLinkage DisequilibriumMiddle AgedNeoplasm StagingApoptosis Regulatory ProteinsErb-b2 Receptor Tyrosine KinasesHigh Mobility Group ProteinsReceptors, EstrogenReceptors, ProgesteroneTOX3 protein, humanTrans-Activators

Identifiers

PMID24481062
PMCPMC3958841
OpenAlexW2038650525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.